blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4073057

EP4073057 - NEW FYN AND VEGFR2 KINASE INHIBITORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  03.10.2024
Database last updated on 02.11.2024
FormerThe patent has been granted
Status updated on  27.10.2023
FormerGrant of patent is intended
Status updated on  17.07.2023
FormerRequest for examination was made
Status updated on  16.09.2022
FormerThe international publication has been made
Status updated on  18.06.2021
Formerunknown
Status updated on  01.01.2021
Most recent event   Tooltip01.11.2024Lapse of the patent in a contracting state
New state(s): SI		published on 04.12.2024 [2024/49]
Applicant(s)For all designated states
Rottapharm Biotech S.r.l.
Via Valosa di Sopra 9
20900 Monza / IT
[2022/42]
Inventor(s)01 / ROVATI, Lucio Claudio
Via Ramazzotti, 1
20900 MONZA / IT
02 / CASELLI, Gianfranco
Via G. Sidoli, 22
20129 MILANO / IT
03 / ARTUSI, Roberto
Via Parri, 21
20017 RHO / IT
04 / MENNUNI, Laura
Via Matteotti, 8
20866 CARNATE / IT
05 / COLACE, Fabrizio
Via C. Montanari, 19/33
20090 MONZA / IT
06 / MANDELLI, Stefano
Via De Gasperi, 61
23880 CASATENOVO / IT
07 / BOVINO, Clara
Via Mazzini, 24
20060 GESSATE / IT
08 / MAGARACI, Filippo
Via Monte Bianco, 25
20090 MONZA / IT
09 / BUZZI, Benedetta
Viale Brianza, 8
20821 MEDA / IT
 [2022/42]
Representative(s)Cattaneo, Elisabetta, et al
Notarbartolo & Gervasi S.p.A.
Viale Achille Papa, 30
20149 Milano / IT
[2022/42]
Application number, filing date20828529.607.12.2020
[2022/42]
WO2020EP84847
Priority number, dateWO2019EP8428709.12.2019         Original published format: PCT/EP2019/084287
[2022/42]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021116005
Date:17.06.2021
Language:EN
[2021/24]
Type: A1 Application with search report 
No.:EP4073057
Date:19.10.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 17.06.2021 takes the place of the publication of the European patent application.
[2022/42]
Type: B1 Patent specification 
No.:EP4073057
Date:29.11.2023
Language:EN
[2023/48]
Search report(s)International search report - published on:EP17.06.2021
ClassificationIPC:C07D401/12, C07D401/14, C07D403/12, C07D413/14, C07D417/12, A61P35/00, C07D417/14, A61K31/506, C07D471/04
[2022/42]
CPC:
C07D403/12 (EP,US); A61P19/02 (US); A61P29/00 (US);
A61P35/00 (EP); C07D231/40 (US); C07D295/155 (US);
C07D401/12 (EP,US); C07D401/14 (EP,US); C07D403/14 (US);
C07D413/14 (EP,US); C07D417/12 (EP,US); C07D417/14 (EP,US);
C07D471/04 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/42]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:NEUE FYN- UND VEGFR2-KINASE-INHIBITOREN[2022/42]
English:NEW FYN AND VEGFR2 KINASE INHIBITORS[2022/42]
French:NOUVEAUX INHIBITEURS DE KINASE FYN ET VEGFR2[2022/42]
Entry into regional phase04.07.2022National basic fee paid 
04.07.2022Designation fee(s) paid 
04.07.2022Examination fee paid 
Examination procedure04.07.2022Amendment by applicant (claims and/or description)
04.07.2022Examination requested  [2022/42]
04.07.2022Date on which the examining division has become responsible
18.07.2023Communication of intention to grant the patent
18.10.2023Fee for grant paid
18.10.2023Fee for publishing/printing paid
18.10.2023Receipt of the translation of the claim(s)
Opposition(s)30.08.2024No opposition filed within time limit [2024/45]
Fees paidRenewal fee
04.07.2022Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT29.11.2023
CZ29.11.2023
DK29.11.2023
EE29.11.2023
HR29.11.2023
LT29.11.2023
LV29.11.2023
MC29.11.2023
NL29.11.2023
PL29.11.2023
RO29.11.2023
RS29.11.2023
SE29.11.2023
SI29.11.2023
SK29.11.2023
SM29.11.2023
IE07.12.2023
IT07.12.2023
LU07.12.2023
BE31.12.2023
BG29.02.2024
NO29.02.2024
GR01.03.2024
IS29.03.2024
PT01.04.2024
[2024/49]
Former [2024/47]AT29.11.2023
CZ29.11.2023
DK29.11.2023
EE29.11.2023
HR29.11.2023
LT29.11.2023
LV29.11.2023
MC29.11.2023
NL29.11.2023
PL29.11.2023
RO29.11.2023
RS29.11.2023
SE29.11.2023
SK29.11.2023
SM29.11.2023
IE07.12.2023
IT07.12.2023
LU07.12.2023
BE31.12.2023
BG29.02.2024
NO29.02.2024
GR01.03.2024
IS29.03.2024
PT01.04.2024
Former [2024/46]AT29.11.2023
CZ29.11.2023
DK29.11.2023
EE29.11.2023
HR29.11.2023
LT29.11.2023
LV29.11.2023
MC29.11.2023
NL29.11.2023
PL29.11.2023
RO29.11.2023
RS29.11.2023
SE29.11.2023
SK29.11.2023
SM29.11.2023
IE07.12.2023
IT07.12.2023
LU07.12.2023
BG29.02.2024
NO29.02.2024
GR01.03.2024
IS29.03.2024
PT01.04.2024
Former [2024/40]AT29.11.2023
CZ29.11.2023
DK29.11.2023
EE29.11.2023
HR29.11.2023
LT29.11.2023
LV29.11.2023
MC29.11.2023
NL29.11.2023
PL29.11.2023
RO29.11.2023
RS29.11.2023
SE29.11.2023
SK29.11.2023
SM29.11.2023
IT07.12.2023
LU07.12.2023
BG29.02.2024
NO29.02.2024
GR01.03.2024
IS29.03.2024
PT01.04.2024
Former [2024/36]AT29.11.2023
CZ29.11.2023
DK29.11.2023
EE29.11.2023
HR29.11.2023
LT29.11.2023
LV29.11.2023
NL29.11.2023
PL29.11.2023
RO29.11.2023
RS29.11.2023
SE29.11.2023
SK29.11.2023
SM29.11.2023
IT07.12.2023
BG29.02.2024
NO29.02.2024
GR01.03.2024
IS29.03.2024
PT01.04.2024
Former [2024/35]AT29.11.2023
CZ29.11.2023
DK29.11.2023
EE29.11.2023
HR29.11.2023
LT29.11.2023
LV29.11.2023
NL29.11.2023
PL29.11.2023
RO29.11.2023
RS29.11.2023
SE29.11.2023
SM29.11.2023
BG29.02.2024
NO29.02.2024
GR01.03.2024
IS29.03.2024
Former [2024/33]DK29.11.2023
HR29.11.2023
LT29.11.2023
LV29.11.2023
NL29.11.2023
PL29.11.2023
RS29.11.2023
SE29.11.2023
SM29.11.2023
BG29.02.2024
NO29.02.2024
GR01.03.2024
IS29.03.2024
Former [2024/27]HR29.11.2023
LT29.11.2023
LV29.11.2023
NL29.11.2023
PL29.11.2023
RS29.11.2023
SE29.11.2023
BG29.02.2024
NO29.02.2024
GR01.03.2024
IS29.03.2024
Former [2024/21]LT29.11.2023
BG29.02.2024
GR01.03.2024
IS29.03.2024
Former [2024/20]GR01.03.2024
IS29.03.2024
Cited inInternational search[A]WO0027822  (BASF AG [DE], et al);
 [A]WO2008157131  (IRM LLC [US], et al);
 [A]WO2009076140  (SMITHKLINE BEECHAM CORP [US], et al);
 [A]EP3070084  (ROTTAPHARM BIOTECH SRL [IT])
by applicantWO2006082001
 WO2008104055
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.